Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Red Cell Half Life Determination in SCD
NCT04476277Phase 1Completed
- Sponsor
- National Heart, Lung, and Blood Institute
- Start
- Apr 2021
- Primary completion
- Dec 2022
- Countries
- 1
01
Overview
Phase 1, open-label trial (4 arms), sponsored by National Heart, Lung, and Blood Institute. Primary endpoint: Mean Red Blood Cells Lifespan at 22 weeks. Started Apr 2021; status: completed.
Beyond the preview
Go deeper on NCT04476277.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04476277.